Home/Filings/4/0000950170-25-093098
4//SEC Filing

Moses Jennifer K. 4

Accession 0000950170-25-093098

CIK 0001590750other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:43 PM ET

Size

5.6 KB

Accession

0000950170-25-093098

Insider Transaction Report

Form 4
Period: 2025-07-01
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-07-01+21,00021,000 total
    Exercise: $14.47Exp: 2035-07-01Common Stock (21,000 underlying)
Footnotes (1)
  • [F1]The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.

Documents

1 file

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1
  • filerCIK 0001706667

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:43 PM ET
Size
5.6 KB